The Board of Pharmacy announced the following effective March 15:
- ARC 6843C has been adopted and amends Chapter 10, “Controlled Substances” placing one substance into Schedule I of the Iowa Controlled Substances Act (CSA) in alignment with .
- ARC 6844C has been adopted and amends Chapter 37, “Iowa Prescription Monitoring Program” establishing council membership information for the PMP Advisory Council and clarifying that only overdoes-reversal opioid antagonists are required to be submitted to the PMP.
Also in Iowa, the Board of Pharmacy issued a “Notice of Intended Action” related to ARC 6874C amending Chapter 10, “Controlled Substances,” and Chapter 12, “Precursor Substances.” This proposed rulemaking temporarily adds four substances to Schedule I, excludes one substance from Schedule II and adds one substance as a precursor substance to the Iowa CSA in alignment with response to similar action taken by the DEA ARC 6874C amending Chapter 10, “Controlled Substances,” and Chapter 12, “Precursor Substances.” This proposed rulemaking temporarily adds four substances to Schedule I, excludes one substance from Schedule II and adds one substance as a precursor substance to the Iowa CSA in alignment with DEA’s action. Comments may be submitted until 4:30 p.m. on February 28.
For more information, contact NACDS’ Sandra Guckian at 703-774-4801.